Pharmsville Co., Ltd. (KOSDAQ:318010)
3,630.00
+10.00 (0.28%)
At close: Aug 24, 2026
Pharmsville Revenue
Pharmsville had revenue of 2.38B KRW in the quarter ending June 30, 2026, a decrease of -22.08%. This brings the company's revenue in the last twelve months to 11.20B, down -21.33% year-over-year. In the year 2025, Pharmsville had annual revenue of 12.73B, down -23.90%.
Revenue (ttm)
11.20B
Revenue Growth
-21.33%
P/S Ratio
2.50
Revenue / Employee
533.42M
Employees
21
Market Cap
27.98B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.73B | -4.00B | -23.90% |
| Dec 31, 2024 | 16.72B | -4.67B | -21.83% |
| Dec 31, 2023 | 21.39B | -4.72B | -18.07% |
| Dec 31, 2022 | 26.11B | -12.91B | -33.09% |
| Dec 31, 2021 | 39.03B | -381.05M | -0.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 199.14B |
| Hurum | 96.85B |
| Korean Drug | 65.39B |
| Kyung Nam Pharm | 56.18B |
| Seoul Pharma | 51.33B |
| Eagle Veterinary Technology Co.,Ltd | 43.61B |
| Union Korea Pharm | 29.66B |
| Daesung Microbiological Labs. | 25.87B |